Preview

Extreme Medicine

Advanced search

Significance of QT interval prolongation in youth and adolescent sports (literature review)

https://doi.org/10.47183/mes.2025-345

Abstract

Introduction. Up to 42% of young athletes who die suddenly show no signs of known cardiac diseases at autopsy (such as cardiomyopathies, myocarditis, or congenital heart defects). However, molecular genetic analysis in young sudden death victims identifies mutations in genes responsible for Long QT Syndrome (LQTS) in 17–23% of cases. During comprehensive medical examinations (CME) of young athletes in Russian national teams within the FMBA of Russia system, up to 24% of athletes are disqualified from sports due to detected QT interval prolongation for further diagnosis, with the diagnosis of LQTS being confirmed in 0.24% of cases.

Objective. Analysis of diagnostic methods for LQTS in young athletes and criteria for their clearance for sports training.

Discussion. The pathogenesis of LQTS is based on genetically determined impairment of cardiac ion channel function, which causes myo- cardial electrical instability predisposing to cardiac events. Such events include Torsades de Pointes (TdP) ventricular tachycardia, syncope, cardiac arrest, and sudden cardiac death (SCD). Diagnosis of LQTS is based on the Schwartz criteria, which incorporate data from standard ECG (QTc > 450 ms), Holter monitoring (HM), stress tests, clinical presentation, and family history. A score of more than three points based on these criteria makes the diagnosis of LQTS highly probable. According to international criteria for QT interval assessment in adult athletes, the proposed upper limits of normal QTc duration are up to 470 ms for males and up to 480 ms for females. Some authors suggest that QTc val- ues up to 500 ms may be acceptable in athletes; however, according to the Schwartz criteria, this value is sufficient to confirm the diagnosis of LQTS. Bradycardia, typical of trained athletes, is another LQTS criterion in pediatric ECG assessment. Methods for QT assessment during bradycardia in young athletes are not specified. Intense training may increase QT interval duration; conversely, temporary detraining may lead to its decrease. The Schwartz criteria based on HM results include only T-wave alternans and TdP tachycardia. QT interval assessment during HM remains a subject of debate. To date, at least 17 pathogenic genes responsible for LQTS have been identified. Detection of Class IV–V pathogenic mutations is sufficient for diagnosing LQTS, regardless of QT duration. The issues of clearance/return to sport-specific training for athletes with LQTS remain controversial, being addressed differently across countries. There are known cases of athletes with LQTS who have achieved significant success in sport competitions, as well as regular occurrences of SCD in young individuals with this condition. Current Russian and international guidelines state that competitive sports are contraindicated for patients with confirmed LQTS.

Conclusions. The assessment of the QT interval in young athletes involves numerous methodological and clinical peculiarities distinct from those in non-athletic individuals. Underestimating these peculiarities can lead to over- or under-diagnosis of LQTS, thereby potentially creat- ing a life-threatening situation for the athlete. Individual risks in different categories of LQTS patients are composed of multiple components. Disqualification from sports does not eliminate the risk of cardiac events in LQTS; at the same time, the extent to which sports activity itself increases these risks remains unknown today. This underscores the relevance of actively studying and clarifying these unresolved issues in young athletes with QT interval prolongation and LQTS.

About the Authors

L. M. Makarov
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency
Russian Federation

Leonid М. Makarov 

Moscow



V. N. Komoliatova
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency
Russian Federation

Vera N. Komoliatova

Moscow



A. G. Akopyan
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency
Russian Federation

Anush G. Akopyan

Moscow



D. A. Besportochnyi
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency
Russian Federation

Dmitryi А. Besportochnyi

Moscow



A. V. Dmitrieva
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency
Russian Federation

Alena V. Dmitrieva

Moscow



I. I. Kiseleva
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency
Russian Federation

Irina I. Kiseleva

Moscow



I. V. Zyabkin
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency
Russian Federation

Ilya V. Zyabkin

Moscow



References

1. Ragazzoni GL, Cavigli L, Cavarretta E, Maffei S, Mandoli GE, Pastore MC, et al. How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation. European Journal of Preventive Cardiology. 2023;30(5):375–83. https://doi.org/10.1093/eurjpc/zwac218

2. Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. European Heart Journal. 2005;26(5):516–24. https://doi.org/10.1093/eurheartj/ehi108

3. Zeppilli P, Biffi A, Cammarano M, Corrado D, Cavarretta E, Cecchi F, et al. Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update 2024. Minerva Medica. 2024;115(5):533–64. https://doi.org/10.23736/s0026-4806.24.09519-3

4. Finocchiaro G, Papadakis M, Robertus JL, Dhutia H, Steriotis AK, Tome M, et al. Etiology of Sudden Death in Sports: Insights from a United Kingdom Regional Registry. JACC. 2016;67:2108–15. https://doi.org/10.1016/j.jacc.2016.02.062

5. Wong LC, Roses-Noguer F, Till JA, Behr ER. Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience. Circulation. Arrhythmia and Electrophysiology. 2014;7(5):800–6. https://doi.org/10.1161/CIRCEP.114.001818

6. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. European Heart Journal. 2008;29(13):1670–80. https://doi.org/10.1093/eurheartj/ehn219

7. Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circulation. Arrhythmia and Electrophysiology. 2012;5(4):868–77. https://doi.org/10.1161/circep.111.962019

8. Makarov LM, Komoliatova VN, Aksenova NV. Analysis of the reasons for exemptions from sports among young elite athletes. Russian Bulletin of Perinatology and Pediatrics. 2020;65(6):65–71 (In Russ.). https://doi.org/10.21508/1027-4065-2020-65-6-65-71

9. Makarov LM, Komoliatova VN, Kiseleva II, Aksenova NV, Besportochny DA, Balykova LA, et al. Epidemiology of syncope in children and adolescents in elite sports (study EPISODE-S). Russian Bulletin of Perinatology and Pediatrics. 2019;64(6):62–7 (In Russ.). https://doi.org/10.21508/1027-4065-2019-64-6-62-67

10. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of Q-T interval and sudden death. American Heart Journal. 1957;54(1):59–68. https://doi.org/10.1016/0002-8703(57)90079-0

11. Schwartz P, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Tome Esteban MT, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761–7. https://doi.org/10.1161/circulationaha.109.863209

12. Wilde AAM, Amin AS, Postema PG. Diagnosis, management and therapeutic strategies for congenital long QT syndrome. Heart. 2022;108(5):332–8. https://doi.org/10.1136/heartjnl-2020-318259

13. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932–63. https://doi.org/10.1016/j.hrthm.2013.05.014

14. Lepeschkin E, Surawicz B. The measurement of the QT interval of the electrocardiogram. Circulation. 1952;6;378–88. https://doi.org/10.1161/01.CIR.6.3.378

15. Sharma S, Drezner JA, Baggish A, Papadakis M, Wilson MG, Prutkin JM, et al. International recommendations for electrocardiographic interpretation in athletes. European Heart Journal. 2017;39:1466–80. https://doi.org/10.1093/eurheartj/ehw631

16. Makarov LM, Kiseleva II, Komoliatova VN, Fedina NN. New norms and interpretations of children’s electrocardiogram. Pediatrics named after G.N. Speransky. 2015;94(2):63–8 (In Russ.). EDN: TUFXDJ

17. Viskin S. The QT interval: too long. too short or just right. Heart Rhythm. 2009;6:711–5. https://doi.org/10.1016/j.hrthm.2009.02.044

18. Orchard JJ, Orchard JW, Raju H, La Gerche A, Puranik R, Davis A, et al. Analysis of athlete QT intervals by age: Fridericia and Hodges heart rate corrections outperform Bazett for athlete ECG screening. Journal of Electrocardiology. 2022;74:59–64. https://doi.org/10.1016/j.hlc.2022.06.145

19. D’Ascenzi F, Anselmi F, Graziano F, Berti B, Franchini A, Bacci E, et al. Normal and abnormal QT interval duration and its changes in preadolescents and adolescents practicing sport. Europace. 2019;21(10):1566–74. https://doi.org/10.1093/europace/euz198

20. Gupta I, Mahendran S, Davis J, Davis A, Orchard J. A Comparison of QT Interval Correction Methods on Electrocardiograms (ECG) of Athletes and Young People: A Systematic Review. Heart, Lung and Circulation. 2022;31(3):S106–7. https://doi.org/10.1016/j.hlc.2022.06.142

21. Hoyte C, Terhune E, Carry P, McCanta A, Coel R. Borderline and Long QT Syndrome in Adolescent Athletes Taking Medications. Journal of Adolescent Health. 2015;57(2):218–21. https://doi.org/10.1016/j.jadohealth.2015.04.003

22. Basavarajaiah S, Wilson M, Whyte G, Shah A, Behr E, Sharma S. Prevalence and significance of an isolated long QT interval in elite athletes. European Heart Journal. 2007;28:2944–9. https://doi.org/10.1093/eurheartj/ehm404

23. Viskin S, Rosovski U, Sands AJ, Chen E, Kistler PM, Kalman JM, et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm. 2005;2(6):569–74. https://doi.org/10.1016/j.hrthm.2005.02.011

24. Małek ŁA, Dotka M, Brzezińska K, Pyndryk P, Materkowski M, Wiecha S. Electrocardiographic Changes in Juvenile Athletes in Relation to Sex, Age, and Sport Category. Pediatric Cardiology. 2025. https://doi.org/10.1007/s00246-025-03945-y

25. Caramoci A, Smaranda AM, Drăgoiu TS, Bădărău IA. ECG Screening in Athletes: A Systematic Review of Sport, Age, and Gender Variations. Reviews in Cardiovascular Medicine. 2025;26(5):38209. https://doi.org/10.31083/RCM38209

26. Park J, Kimata C, Young J, Perry JC, Bratincsak A. Fine Tuning ECG Interpretation for Young Athletes: ECG Screening Using Z-score-based Analysis. Sports Medicine — Open. 2024;10:114. https://doi.org/10.1186/s40798-024-00775-9

27. Schnell F, Behar N, Carré F. Long-QT Syndrome and Competitive Sports. Arrhythmia and Electrophysiology Reviews. 2018;7(3):187–92. https://doi.org/10.15420/aer.2018.39.3

28. Dagradi F, Spazzolini C, Castelletti S, Pedrazzini M, Kotta MC, Crotti L, et al. Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome. Circulation. 2020;142(25):2405–15. https://doi.org/10.1161/CIRCULATIONAHA.120.048916

29. Yanık H, Değirmenci E, Büyükakıllı B. A comprehensive electrocardiographic analysis for young athletes. Medical and Biological Engineering and Computing. 2021;59(9):1865–76. https://doi.org/10.1007/s11517-021-02401-2

30. Zareba W. Challenges of diagnosing long QT syndrome in patients with nondiagnostic resting QTc. JACC. 2010;55(18):1962–4. https://doi.org/10.1016/j.jacc.2010.02.018

31. Garson A. How to measure the QT interval–what is normal? American Journal of Cardiology. 1993;72(6):14B–16B. https://doi.org/10.1016/0002-9149(93)90034-a

32. Eggeling T, Osterhues HH, Kochs M, Beyer M, Höher M, Hombach V. Diagnostische Wertigkeit von Standard-EKG-Methoden, Kälte-Druck-Test und Valsalva-Manöver beim idiopathischen QT-Syndrom. Zeitschrift gur Kardiologie. 1993;82(1):1–7.

33. Makarov L, Komoliatova V, Zaklyazminskaya E, Dmitrieva A. Ambulatory ECG Monitoring in Patients with Long QT Syndrome. Conference: Scientific Session AHA. Chicago; 2018. https://doi.org/10.13140/RG.2.2.32275.69921

34. Page A, Aktas MK, Soyata T, Zareba W, Couderc JP. “QT clock” to improve detection of QT prolongation in long QT syndrome patients. Heart Rhythm. 2016;13(1):190–8. https://doi.org/10.1016/j.hrthm.2015.08.037

35. Follansbee CW, Beerman L, Arora G. Automated QT analysis on Holter monitors in pediatric patients can differentiate long QT syndrome from controls. PACE. 2018;41(1):50–6. https://doi.org/10.1111/pace.13244

36. Makarov LM, Komoliatova VN, Miroshnikova EN, Kazantseva MA. Physiological significance and normative parameters of rate adaptation of QT-interval during Holter monitoring in healthy persons of young age. Kardiologiia. 2008;48(4):54–8 (In Russ.).

37. Genovesi S, Zaccaria D, Rossi E, Valsecchi MG, Stella A, Stamba-Badiale M. Effects of exercise training on heart rate and QT interval in healthy young individuals: are there gender differences? Europace. 2007;9(1):55–60. https://doi.org/10.1093/europace/eul145

38. Makarov L, Komoliatova V, Zevald S, Schmidt G, Muller CA, Serebruany V. QT dynamicity, microvolt T-wave alternans, and heart rate variability during 24-hour ambulatory electrocardiogram monitoring in the healthy newborn of first to fourth day of life. Journal of Electrocardiology. 2010;43(1):8–14. https://doi.org/10.1016/j.jelectrocard.2009.11.001

39. Makarov L. The component of pathogenesis of sudden nocturnal death in patients with heart failure. Extreme Medicine. 2022;24(3):74–6. https://doi.org/10.47183/mes.2022.026

40. Viskin S, Postema PG, Bhuiyan ZA, Rosso R, Kalman JM, Vohra JK, et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. JACC. 2010;55(18):1955–61. https://doi.org/10.1016/j.jacc.2009.12.015

41. Hoyte C, Terhune E, Carry P, McCanta A, Coel R. Borderline and Long QT Syndrome in Adolescent Athletes Taking Medications. Journal of Adolescent Health. 2015;57(2):218–21. https://doi.org/10.1016/j.jadohealth.2015.04.003

42. Yunisova AS, Smolensky AV. Acquired long QT interval in athletes. Sports Medicine: Research and Practice. 2021;11(4):17–25 (In Russ.). https://doi.org/10.47529/2223-2524.2021.4.3

43. Makarov LM, Komoliatova VN, Kiseleva II, Besportochnyi DA, Dmitrieva AV, Akopyan AG, et al. Long QT syndrome is a disease with a high risk of sudden death. Moscow: PH “Medpraktika-M”; 2018 (In Russ.).

44. Makarov LM, Komoliatova VN, Zaklyazminskaya EV, Besportochnyi DA, Akopyan AG, Islanov IO, et al. 2 Cases of New Electrocardiographic Patterns in Patients with Long QT Syndrome. JACC: Case Reports. 2025;30(15):103753. https://doi.org/10.1016/j.jaccas.2025.103753

45. Pelliccia A. Long QT syndrome, implantable cardioverter defibrillator (ICD) and competitive sport participation: when science overcomes ethics. British Journal of Sports Medicine. 2014;48(15):1135–6. https://doi.org/10.1136/bjsports-2013-092441

46. Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109(15):1826–33. https://doi.org/10.1161/01.CIR.0000125523.14403.1E

47. Basavarajaiah S, Sharma S. (2009). A 16-Year-Old Female Runner with Prolonged QT Interval. Sports Cardiology Casebook. London: Springer; 2009. https://doi.org/10.1007/978-1-84882-042-5_13

48. Pellicia A, Heidbuchel H, Corrado D, Sharma S, Borjesson М. Criteria and considerations relative to safe participation in sport for athletes with cardiac abnormalities. The ESC Textbook of Sport Cardiology. Oxford: Oxford university press; 2019. https://doi.org/10.1093/med/9780198779742.003.0041

49. Makarov LM. Holter monitoring. 4-th edition. Moscow: “Medpraktika-M”; 2017 (In Russ.).

50. Johnson JN, Ackerman MJ. Return to play? Athletes with congenital long QT syndrome. British Journal of Sports Medicine. 2013;47(1):28–33. https://doi.org/10.1136/bjsports-2012-091751

51. Aziz PF, Sweeten T, Vogel RL, Bonney WJ, Henderson J, Patel AR, et al. Sports Participation in Genotype Positive Children with Long QT Syndrome. JACC Clinical Electrophysiology. 2015;1(1–2):62–70. https://doi.org/10.1016/j.jacep.2015.03.006

52. Longo UG, Risi Ambrogioni L, Ciuffreda M, Maffulli N, Denaro V. Sudden cardiac death in young athletes with long QT syndrome: the role of genetic testing and cardiovascular screening. British Medical Bulletin. 2018;127(1):43–53. https://doi.org/10.1093/bmb/ldy017

53. Corrado D, Trovato D, Zorzi A. Long QT Syndrome: A Preventable Cause of Exercise-Induced Sudden Cardiac Death. JACC Case Reports. 2023;22:101991. https://doi.org/10.1016/j.jaccas.2023.101991

54. Boytsov SA, Kolos IP, Lidov PI, Smolenskyi AV, Ardashev AV, Balykova LA, et al. National recommendations for admission of athletes with cardiovascular disorders to the training and competition process. Rational Pharmacotherapy in Cardiology. 2011;7(6S) (In Russ.). EDN: OPRUET

55. Mazzanti A, Trancuccio A, Kukavica D, Pagan E, Wang M, Mohsin M, et al. Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk). Europace. 2022;24(4):614–9. https://doi.org/10.1093/europace/euab238


Supplementary files

Review

For citations:


Makarov L.M., Komoliatova V.N., Akopyan A.G., Besportochnyi D.A., Dmitrieva A.V., Kiseleva I.I., Zyabkin I.V. Significance of QT interval prolongation in youth and adolescent sports (literature review). Extreme Medicine. (In Russ.) https://doi.org/10.47183/mes.2025-345

Views: 12


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2713-2757 (Print)
ISSN 2713-2765 (Online)